A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

NCT07018713 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

780

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Migraine

Interventions

DRUG: Xeomin
DRUG: Placebo

Sponsor

Merz Therapeutics GmbH